Novavax Inc (NVAX)

160.48
-1.49(-0.92%)
After Hours
160.75
+0.27(+0.17%)
- Real-time Data
  • Volume:
    4,421,684
  • Bid/Ask:
    160.59/160.75
  • Day's Range:
    156.00 - 169.00

NVAX Overview

Prev. Close
161.97
Day's Range
156-169
Revenue
1.2B
Open
168.39
52 wk Range
106.12-331
EPS
-14.82
Volume
4,421,684
Market Cap
12.13B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
5,200,039
P/E Ratio
-
Beta
1.3
1-Year Change
27.11%
Shares Outstanding
75,608,073
Next Earnings Date
27 Feb 2022
What is your sentiment on Novavax Inc?
or
Market is currently closed. Voting is open during market hours.

Novavax Inc Company Profile

Employees
792

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellBuy
Technical IndicatorsStrong BuySellStrong SellStrong SellBuy
SummaryStrong BuyNeutralStrong SellStrong SellBuy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.